IRCT20081130001475N12已完成1 期
Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (Sinaampholeish) in comparison with placebo on Healthy Volunteers; Phase I Clinical Trial.
eglected Diseases Initiative0 个研究点目标入组 27 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Healthy volunteer
- •aged between 18-65
- •willingness to participate in the study and signing the informed consent form
排除标准
- •Any disease or illness according to subject history
- •Mentally ill based on physician diagnosis
- •participating in other concurrent trial
研究者
相似试验
已完成
2 期
Efficacy of topical Nano-liposomal Amphotericin B 0.4% for Treatment of OnychomycosisIRCT20150101020514N18Center For Research and Training in Skin Disease and Leprosy15
已完成
2 期
Evaluation the efficacy of topical naloxane on Controlling of Chronic Prupritus Induced By Chemical InjuriesChronic Prupritus Induced By Chemical Injuries.Irritant contact dermatitisL24L29PruritusIRCT201702221165N17Baghiyatallah University70
已完成
3 期
safety and efficacy comparison trial of topical nano-liposomal form of Amphotericin B with national standard treatment for cutaneous leishmaniasis caused by Leishmania major (Phase 3)Cutaneous Leishmaniasis.Cutaneous leishmaniasisIRCT201612101475N11ational Institute for Medical Research Development (NIMAD)150
已完成
2 期
Comparative study of nano-emulsion fluconazole gel with oral form in dermatophyte treatmentTinea corporisIRCT20190326043113N1Sari University of Medical Sciences40
已完成
1 期
Evaluation of efficacy of topical Naloxone® in control of neurotic pruritusNeurotic excoriationeurodermatitis.IRCT201702231165N18Baqiyatallah University of medical sciences70